Ludwigshafen, Germany Contract Manufacturing Capabilities

AbbVie’s Ludwigshafen facility is situated in the heart of the Rhine Neckar biotechnology region in Western Central Germany, approximately 60 miles south of Frankfurt.

The site has been in operation since 1886, and continues to thrive as a center of excellence for drug product research, development and manufacturing.

AbbVie’s Ludwigshafen facility offers specialized services for oral solid dosage forms.

AbbVie’s German manufacturing site specializes in innovative solutions for solid dosage forms, including cutting-edge hot melt extrusion capabilities to offer solutions to challenging API formulation. This unique resource provides pharmaceutical companies worldwide access to cutting edge technologies and technical expertise.

With focused technology and personnel, one of many technologies our leading German pharmaceutical manufacturer excels in is processing of poorly-soluble API’s via Hot Melt Extrusion.

AbbVie’s Ludwigshafen, Germany cGMP manufacturing expertise:

  • Massing Granulation (High Shear)
  • Massing Granulation (Low Shear)
  • Drying Granulation (Fluid Bed)
  • Compressing Granulation (Roller Compactor)
  • Direct Compression (Dry Blend)
  • Bi-layer Tablets
  • Micro-tablets
  • Tablet Coating
  • Capsules
  • Hot Melt Extrusion
  • Packaging: Blisters, Bottles, Liquids

An AbbVie CMO representative is eager to talk to you.

AbbVie CMO is a seasoned partner for all your contract manufacturing needs. Let’s start a conversation today. The future is a click away.